Markery nowotworowe (Polish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Markery nowotworowe" in Polish language version.

refsWebsite

Global rank Polish rank

9nih.gov

4^th place

7^th place

8worldcat.org

5^th place

2^nd place

1metabolic-database.com

low place

1nature.com

234^th place

204^th place

1doi.org

2^nd place

6^th place

1lww.com

2,769^th place

1,863^rd place

doi.org

dx.doi.org

J.J. Schneider J.J. i inni, Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients, „Clinical and Experimental Medicine”, 2 (4), 2003, s. 185–191, DOI: 10.1007/s102380300005, ISSN 1591-8890, PMID: 12624710 .

lww.com

journals.lww.com

Kumar, Yogesh; Tapuria, Niteen (2007): Tumour M2-pyruvate kinase: a gastrointestinal cancer marker European Journal of Gastroenterology & Hepatology: March 2007 - Volume 19 - Issue 3 - pp 265-276

metabolic-database.com

Eigenbrodt E, Mazurek S Tumor Metabolome [dostęp 2011-09-30]

nature.com

U Haug, D Rothenbacher Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients Br J Cancer 96: 1329-1334

nih.gov

ncbi.nlm.nih.gov

D.D. Lüftner D.D. i inni, Tumor type M2 pyruvate kinase expression in advanced breast cancer, „Anticancer Research”, 20 (6D), 2000, s. 5077–5082, ISSN 0250-7005, PMID: 11326672 .
CarinaC. Benesch CarinaC. i inni, The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer, „Anticancer Research”, 30 (5), 2010, s. 1689–1694, ISSN 1791-7530, PMID: 20592362 .
G.M.G.M. Oremek G.M.G.M. i inni, Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma, „Anticancer Research”, 20 (6D), 2000, s. 5095–5098, ISSN 0250-7005, PMID: 11326675 .
H.W.H.W. Wechsel H.W.H.W. i inni, Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK), „Anticancer Research”, 19 (4A), 1999, s. 2583–2590, ISSN 0250-7005, PMID: 10470199 .
J.J. Schneider J.J. i inni, Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients, „Clinical and Experimental Medicine”, 2 (4), 2003, s. 185–191, DOI: 10.1007/s102380300005, ISSN 1591-8890, PMID: 12624710 .
G.G. Oremek G.G. i inni, [The significance of TU M2-PK tumor marker for lung cancer diagnostics], „Klinicheskaia Meditsina”, 85 (7), 2007, s. 56–58, ISSN 0023-2149, PMID: 17882813 (ros.).
P.D.P.D. Hardt P.D.P.D. i inni, Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer, „Anticancer Research”, 20 (6D), 2000, s. 4965–4968, ISSN 0250-7005, PMID: 11326648 .
Kaura B, Bagga R, Patel FD.(2004): Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma J Obstet Gynaecol Res. 2004 Jun;30(3):193-6.
A.S.A.S. Ahmed A.S.A.S. i inni, M2-PK as a novel marker in ovarian cancer. A prospective cohort study, „European Journal of Gynaecological Oncology”, 28 (2), 2007, s. 83–88, ISSN 0392-2936, PMID: 17479666 .

worldcat.org

D.D. Lüftner D.D. i inni, Tumor type M2 pyruvate kinase expression in advanced breast cancer, „Anticancer Research”, 20 (6D), 2000, s. 5077–5082, ISSN 0250-7005, PMID: 11326672 .
CarinaC. Benesch CarinaC. i inni, The clinicopathological and prognostic relevance of pyruvate kinase M2 and pAkt expression in breast cancer, „Anticancer Research”, 30 (5), 2010, s. 1689–1694, ISSN 1791-7530, PMID: 20592362 .
G.M.G.M. Oremek G.M.G.M. i inni, Value of tumor M2 (Tu M2-PK) in patients with renal carcinoma, „Anticancer Research”, 20 (6D), 2000, s. 5095–5098, ISSN 0250-7005, PMID: 11326675 .
H.W.H.W. Wechsel H.W.H.W. i inni, Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK), „Anticancer Research”, 19 (4A), 1999, s. 2583–2590, ISSN 0250-7005, PMID: 10470199 .
J.J. Schneider J.J. i inni, Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients, „Clinical and Experimental Medicine”, 2 (4), 2003, s. 185–191, DOI: 10.1007/s102380300005, ISSN 1591-8890, PMID: 12624710 .
G.G. Oremek G.G. i inni, [The significance of TU M2-PK tumor marker for lung cancer diagnostics], „Klinicheskaia Meditsina”, 85 (7), 2007, s. 56–58, ISSN 0023-2149, PMID: 17882813 (ros.).
P.D.P.D. Hardt P.D.P.D. i inni, Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer, „Anticancer Research”, 20 (6D), 2000, s. 4965–4968, ISSN 0250-7005, PMID: 11326648 .
A.S.A.S. Ahmed A.S.A.S. i inni, M2-PK as a novel marker in ovarian cancer. A prospective cohort study, „European Journal of Gynaecological Oncology”, 28 (2), 2007, s. 83–88, ISSN 0392-2936, PMID: 17479666 .